Proteomic and phenotypic analysis of triclosan tolerant verocytotoxigenic Escherichia coli O157: H19

Journal of Proteomics

Volumn 80, Issue , 2013, Pages 78-90

  Sheridan, A ^a,b   Lenahan, M ^a   Condell, O ^a,b   Bonilla Santiago, R ^b   Sergeant, K ^c   Renaut, J ^c   Duffy, G ^a   Fanning, S ^b   Nally, J E ^b   Burgess, C M ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

Biofilm; DIGE; FabI; Triclosan tolerance; Verocytotoxigenic Escherichia coli (VTEC)

Indexed keywords

2 NAPHTHYLAMINE; BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN; OXIDOREDUCTASE; PROTEOME; STRUCTURAL PROTEIN; TRICLOSAN; ACYL COENZYME A DEHYDROGENASE; CARBOCYANINE; CELLULOSE; CYANINE DYE 1; DIPEPTIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; BIOFILM; CONTROLLED STUDY; ESCHERICHIA COLI O157; FLAGELLUM; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; BACTERIUM ADHERENCE; CACO 2 CELL LINE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOBLOTTING; MASS SPECTROMETRY; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION; PROCEDURES; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACYL-COA DEHYDROGENASES; BACTERIAL ADHESION; BIOFILMS; CACO-2 CELLS; CARBOCYANINES; CELLULOSE; DIPEPTIDES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MUTATION; OXIDOREDUCTASES; PHENOTYPE; PROTEOME; PROTEOMICS; TRICLOSAN;

EID: 84873615722     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.12.025     Document Type: Article

References (53)

1. Coia J.E. Clinical, microbiological and epidemiological aspects of Escherichia coli O157 infection. FEMS Immunol Med Microbiol 1998, 20:1-9.
2. Karmali A. Host and pathogen determinant of verocytotoxin-producing Escherichia coli-associated haemolytic uremic syndrome. Kidney Int 2009, 75:4S-7S.
3. Chase-Topping M., Gally D., Low J.C., Mathews L., Woolhouse M.E.J. Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nat Rev Microbiol 2008, 6:904-912.
4. Langsrud S., Sidhu M.S., Heir E., Holck A.L. Bacterial disinfectant resistance - a challenge for the food industry. Int Biodeter Biodegr 2003, 51:283-290.
5. McMurry L.M., Oethinger M.M., Levy S.B. Over expression of marA, soxS or acrB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998, 166:305-309.
6. Levy C.W., Roujeinikova A., Sedelnikova S., Baker P.J., Stuitje A.R., Slabas A.R., et al. Molecular basis of triclosan activity. Nature 1999, 398:383-384.
7. Heath R.J., Rubin J.R., Holland D.R., Zhang E., Snow M.E., Rock C.O. Mechanisms of triclosan inhibition of bacterial fatty acid synthesis. Biochemistry 1999, 274:11110-11114.
8. Sivaraman S., Zwahlen J., Bell A.F. Structure activity studies on the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan, kinetic analysis of mutant FabIs. Biochemistry 2003, 46:4406-4413.
9. Webber M.A., Coldham N.G., Woodward M.J., Piddock L.J.V. Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008, 62:92-97.
10. Webber M.A., Randall L.P., Cooles S., Woodward M.J., Piddock L.J.V. Triclosan resistance in Salmonella enterica Serovar Typhimurium. J Antimicrob Chemother 2008, 62:83-91.
11. Levy S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992, 36:695-703.
12. Levy S.B. Active efflux; a common mechanism for biocide and antibiotic resistance. J Appl Microbiol 2002, 92:65S-71S.
13. Piddock L.J. Multidrug resistance efflux pumps-not just from resistance. Nat Rev Microbiol 2006, 8:629-636.
14. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
15. Thomas K.M., Mccann M.S., Collery M.M., Logan A., Whyte P., McDowell D.A., et al. Tracking verocyotoxigenic Escherichia coli O157, O26, O111, O103 in Irish cattle. Int J Food Microbiol 2012, 153:288-296.
16. Sheridan A., Lenahan M., Duffy G., Fanning S., Burgess C. The potential for biocide tolerance in Escherichia coli and its impact on the response to food processing stresses. Food Control 2012, 26:98-106.
17. Condell O., Sheridan A., Power K.A., Bonilla-Santiago R., Sergeant K., Renaut J., et al. Comparative proteomic analysis of Salmonella tolerance to the biocide active agent triclosan. J Proteomics 2012, 75:4505-4519.
18. Solano C., Garcia B., Valle J., Barasain C., Ghigo J.C., Gamazo C., et al. Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. Mol Microbiol 2002, 43:793-808.
19. Bailey A.M., Constantinidou C., Ivens Al, Garvey M.I., Webber M.A., Coldham N., et al. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother 2009, 64:973-985.
20. Stepanovic S., Vukovic D., Dakic I., Savic B., Svablic-Vlahovic M. A modified microtitre-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000, 40:175-179.
21. Schembri M.A., Kjaergaard K., Klemm P. Global gene expression in Escherichia coli biofilms. Mol Microbiol 2003, 48:253-267.
22. Russell A.D. Plasmids and bacterial resistance to biocides. J Appl Microbiol 1997, 83:155-165.
23. Karatzas K.A.G., Webber M.A., Jorgensen F., Woodward M.J., Piddock L.J.V., Humphrey T.J. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 2007, 60:947-955.
24. Heath R.L., Yu Y.T., Shapiro M.A. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 1998, 273:30316-30320.
25. Lu H., Tonge P.J. Drug-target residence time: critical information for lead optimization. Curr Opin Chem Biol 2008, 66:564-573.
26. Yu B.J., Kim J.A., Pan J.G. Signature gene expression profile of triclosan-resistant Escherichia coli. J Antimicrob Chemother 2010, 65:1171-1177.
27. Heath R.J., Rock C.O. A triclosan-resistant bacterial enzyme. Nature 2000, 2000:406-411.
28. Karatzas K.A.G., Randall L.P., Webber M., Piddock L.J.V., Humphrey T.J., Woodward M.J., et al. Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol 2008, 74:1508-1516.
29. Bore E., Hebraud M., Chafsey I., Chambon C., Skjaeret C., Moen B., et al. Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses. J Microbiol 2007, 153:935-946.
30. Mohan N.M.K., Venkitanarayanan K. Role of bacterial OmpA and host cytoskeleton in the invasion of human intestinal epithelial cells by Enterobacter sakazakii. Pediatr Res 2007, 62:664-669.
31. Orme R., Douglas C.W., Rimmer S., Webb M. Proteomic analysis of Escherichia coli biofilms reveals the over expression of the outer membrane OmpA. Proteomics 2006, 6:4269-4277.
32. Mecsas J., Welch R., Erickson J.W., Gross C.A. Identification and characterization of an outer membrane protein, OmpX, in Escherichia coli that is homologous to a family of outer membrane proteins including Ail of Yersinia enterocolitica. J Bacteriol 1995, 177:799-804.
33. Viveiros M., Dunpont M., Rodrigues L., Couto L., Davin-Regli A., Martins M., et al. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2007, 2:e365.
34. Henderson I.R., Nataro J.P. Virulence functions of autotransporter proteins. Infect Immunol 2001, 69:1231-1243.
35. Pallen M.J., Chaudhuri R.R., Henderson I.R. Genomic analysis of secretion systems. Curr Opin Microbiol 2003, 6:519-527.
36. Desvaux M., Parham N.J., Henderson I.R. The autotransporter secretion system. Res Microbiol 2004, 155:53-60.
37. Henderson I.R., Navarro-Garcia F., Desvaux M., Fernandez R.C., Ala'Aldeen D. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004, 68:692-744.
38. SCENIHR (Scientific Committee on Emerging, Newly Identified Health Risks) Research strategy to address the knowledge gaps on the antimicrobial resistance effects of biocides March 17 2010.
39. Danese P.N., Pratt L.A., Dove S.L., Kolter R. The outer membrane protein, Antigen 43, mediates cell to cell interactions within Escherichia coli biofilms. Mol Microbiol 2000, 37:424-432.
40. Bokranz W., Wang X., Tschape H., Romling U. Expression of cellulose and curl fimbriae by Escherichia coli isolated from the gastrointestinal tract. J Med Microbiol 2005, 54:I1171-I1182.
41. Pawar D.M., Rossman M.L., Chen J. Role of curli fimbriae in mediating the cells of enterohaemorrhagic Escherichia coli to attach to abiotic surfaces. J Appl Microbiol 2005, 99:418-425.
42. Uhlich G.A., Cooke P.A., Solomon E.B. Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 2006, 72:2564-2572.
43. Cruz Ramos H., Rumbo M., Sirard C.J. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 2004, 11:509-517.
44. Pratt L.A., Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 1998, 30:285-293.
45. Weir E.K., Martin C.L., Poppe C., Coombes B.K., Boerlin P. Subinhibitory concentrations of tetracycline affect virulence gene expression in a multi-resistant Salmonella enterica subsp. enterica serovar Typhimurium DT104. Microbes Infect 2008, 10:901-907.
46. Llorca O., Galan A., Carrascosa J.L., Muga A., Valpuesta J.M. GroEl under heat shock, switching from a folding to a storing function. J Biol Chem 1998, 273:32587-32594.
47. Guo B., Abdelraouf K., Ledesma R.K., Nikolaou M., Tam H.V. Predicating bacterial fitness cost associated with drug resistance. J Antimicrob Chemother 2012, 67:928-932.
48. Valeria dos Santos K., Diniz C.G., de Castro Veloso L., Monteiro de Andrade H., da Silva Giusta M., da Fonseca Pires S., et al. Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/taobactam. Res Microbiol 2010, 161:268-275.
49. O' Neill A.J., Huovinen T., Fishwick C.W. Molecular genetic and structural modelling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 2006, 50:298-309.
50. Foucault M.L., Courvalin P., Grillot-Courvalin C. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:2354-2359.
51. Levin B.R., Perrot V., Walker N. Compensatory mutations, antibiotic resistance and population genetics of adaptive evolution in bacteria. Genetics 2000, 54:985-997.
52. Reynolds M.G. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 2000, 156:1471-1481.
53. Walsh S.E., Maillard J.-Y., Russell A.D., Catrenich C.E., Charbonneau C.E., Bartolo R.G. Activity and mechanisms of action of selected biocidal agents on Gram-positive and negative bacteria. J Appl Microbiol 2003, 94:240-247.